A Model for Developing, Implementing and Integrating Patient Advisory Committees in Opioid Treatment Programs
Robert E. Sage, PhD, Addiction Research and Treatment Corporation, Brooklyn, NY; Monice A. Joseph, CSW, Addiction Research and Treatment Corporation, Brooklyn, NY; Ralph J. Savarese, Med, Addiction Research and Treatment Corporation, Brooklyn, NY

Patient Advisory Committees (PAC) are valuable mechanisms to strengthen managerial and programmatic decision-making, while enhancing patient input and feedback. This workshop demonstrates a practice-based approach that identifies the role and integration of management, clinical staff and patients in establishing and sustaining the PAC and achieving established objectives.

Click here to download presentation (Powerpoint)

An NTP Affiliated Office-Based Opiate Treatment (OBOT) Program in a Public Setting
Alice Gleghorn, PhD, San Francisco Department of Public Health Community Behavioral Health Services, San Francisco, CA; David Hersh, MD, UCSF, San Francisco, CA; Sharon Kotabe, PharmD, Community Health Network of San Francisco, San Francisco, CA

The San Francisco Department of Public Health OBOT program provides office-based opiate addiction treatment with methadone and buprenorphine to opiate dependent individuals. The presentation will include: program overview; background of its design and implementation; clinical review of buprenorphine/methadone treatment protocols; and issues specific to community-based pharmacy services. Preliminary compliance and outcomes indicators will be discussed.

Click here to download presentation (Powerpoint)
Click here to download presentation (Powerpoint)

Assessment and Treatment Planning for the Clinician
Cynthia Banfield-Weir, LICSW, Community Health Care, Chicopee, MA

As opioid treatment providers meet accreditation standards, clinicians are being asked to demonstrate clinical competence through their ability to complete an assessment and develop a treatment plan that describes an outline for change. This workshop is designed to assist clinicians in assessment and treatment planning.

Click here to download presentation (Powerpoint)
Click here to download handout (PDF)

Contingency Management Approach: Implementation and Outcomes
Peter Coleman, MS, New York City Health and Hospitals Corporation, New York, NY; Scott Kellogg, PhD, The Rockefeller University, New York, NY; Marylee Burns, Med, New York City Health and Hospitals Corporation, New York, NY

Presenters will describe how a large municipal hospital system collaborated with researchers to implement a contingency management approach within its methadone treatment programs. Presenters will also discuss the exciting results of this initiative: Galvanized and empowered staff, patients with increased motivation to participate in the recovery process and dramatically changes patient expectations and clinic environments.

Click here to download presentation (Powerpoint)

Ethnic and Cultural Considerations in the Clinical Management of Mental Illness and Substance Abuse
Beny J. Primm, MD, Addiction Research and Treatment Corporation, Brooklyn, NY; Annelle B. Primm, MD, Department of Psychiatry and Behavioral Sciences, John Hopkins Hospital, Baltimore, MD

This presentation will provide participants with an understanding of the complexities of clinical care of mental illness and substance abuse in members of the four major underserved and underrepresented ethnic and racial groups in the United States.

Click here to download presentation (Powerpoint)

Even Borderlines Get the Blues: Treating the Person, Not Just the Problem
Neil Bomar, MD, Memphis Center for Research and Addiction Treatment, Memphis, TN; Anne Knight, LCSW, Memphis Center for Research and Addiction Treatment, Memphis, TN

This workshop will focus on the importance of using the DSM IV/Axis II in the treatment if opioid dependent individuals. Strategies for treatment planning, realistic goal setting, and clinical tools will be discussed. As overview of the work of Linehan, Kernberg, Beck and Masterson will also be provided.

Click here to download handout (PDF)
Click here to download handout (PDF)

Evidence-Based Interventions for Difficult Clinical Challenges
Michael McCann, MA, Matrix Institute, Los Angeles, CA; Dan George, Matrix Institute, Los Angeles, CA; Albert Hasson, MSW, Matrix Institute, Los Angeles, CA

HIV risk behaviors, stimulant abuse and poor attendance are among the most taxing clinical problems counselors must address. Presenters will describe specific interventions including a women's group targeting HIV risk behaviors, the Matrix Model for stimulant use and a low cost contingency management procedure to improve attendance.

Click here to download presentation (Powerpoint)
Click here to download presentation (Powerpoint)

Hepatitis C Treatment: Support, Empowerment and Education
Alain Litwin, MD, Albert Einstein College of Medicine, New York, NY; Irene Soloway, RPA-C, Albert Einstein College of Medicine, Bronx, NY; Frank Medina, PE, Albert Einstein College of Medicine, Bronx, NY

Partner Up! Learn about the power of partnerships between patients and clinicians in the treatment of chronic hepatitis C. We will illustrate the process of implementing a hepatitis C support group and a peer education-training program where ultimately patients emerge as health leaders motivating others in the community to seek treatment.

Click here to download handout (PDF)
Click here to download handout (PDF)

Maintaining Accreditation: Meeting the Challenges of Compliance
Megan Marx, MPA, Joint Commission of Healthcare Organizations, Littleton, CO; Mary Cesare-Murphy, PhD, Joint Commission on Accreditation of Healthcare Organizations, Oakbrook Terrace, IL

This workshop will provide a review of commonly cited Joint Commission accreditation standards and discuss compliance strategies. Presenters will also share tips for completing the periodic performance review and how to use it as a risk management resource. Finally, presenters will address the use of data to improve program performance.

Click here to download presentation (Powerpoint)

Medical Aspects of Methadone
Judith Martin, MD, 14th Street Clinic, Oakland, CA

This workshop is part of the Basic series intended for entry level counselors. It will review the elements of opioid agonist treatment, such as close, side effects and duration of MMT. It will cover pharmacologic aspects such as half-life, receptor site, blood level and paid metabolizer. It is intended to provide a language to engage the patient who is concerned about his or her medication in a therapeutic way.

Click here to download presentation (Powerpoint)
Click here to download handout (PDF)

Pharmacotherapy during Pregnancy: Methadone, Buprenorphine, and Neonatal Abstinence Syndrome
Karol Kaltenbach, PhD, Jefferson Medical College, Philadelphia, PA; John McCarthy, MD, Bi-Valley Medical Clinic, Sacramento, CA; Hendree Jones, PhD, Johns Hopkins University, Baltimore, M.D.

This workshop will address maternal and infant outcomes utilizing methadone and buprenorphine pharmacotherapy. Presenters will discuss the relationship of maternal methadone dose and neonatal abstinence, maternal and infant outcomes for women treated with up to 190mg of methadone per day, and the safety and efficacy of using buprenorphine during pregnancy.

Click here to download presentation (Powerpoint)
Click here to download presentation (Powerpoint)

Prescription Opioid Dependence
Usoa Busto, PhD, Center for Addiction and Mental Health, Toronto, Canada; Steven Clay, DO, Ohio University College of Osteopathic Medicine, Athens, OH; Aaron Gilson, PhD, University of Wisconsin, Madison, WI; Robert Walsh, RAC, NIDA (Facilitator)

Prescription opioid medications can help to improve the quality of life of individuals with severe pain and other medical conditions. However, some of these medications may be abused. The purpose of this workshop is to discuss the nature and extent of the problem of the prescription opioid dependence as well as its prevention and treatment.
NIDA Sponsored Workshop

Click here to download presentation (Powerpoint)
Click here to download presentation (Powerpoint)
Click here to download presentation (Powerpoint)

Psychiatric Co-Morbidity
Joan E. Zweben, PhD, Berkeley, CA

This workshop will discuss how counselors can help integrate the treatment of psychiatric disorders into the methadone treatment program. We will discuss addictive behavior and coexisting psychiatric problems, barriers to addressing them, how to educate patients appropriately, how to prioritize treatment tasks and how to work with physicians around psychotropic medication.

Click here to download presentation (Powerpoint)

Residential Treatment: "What's Methadone Got to Do With It"
Siara Andrews, PsyD, UCSF-SFGH, San Francisco, CA; Yong Song, PhD, SFGH-Ward 93, San Francisco, CA; Steve Myers, MC, Walden House, San Francisco, CA

This workshop presents research-investigating treatment of methadone maintenance patients in residential treatment. This practical workshop will provide ideas for treatment expansion and methodology for building ties between methadone programs and therapeutic communities, with the goal of improving the effectiveness of care for opioid dependence.

Click here to download presentation (Powerpoint)
Click here to download handout (PDF)

Spirituality and Opioid Treatment
Lisa Cook, LSW, Drug Addiction Services of Hawaii, Honolulu, HI, Marcia Tsue Horiuchi, MSW, Drug Addiction Services of Hawaii, Honolulu, HI; Sarah Kelaukila Center, Kuma, Drug Addiction Services of Hawaii, Pahoa, HI

OTPS can fall into the trap of holding the regulations and medication management as the core of the program. This workshop will describe culturally based programming the full integration of spirituality in all aspects of management, corporate values, decision making, assessment, treatment interventions outcomes and program curriculum.

Click here to download presentation (Powerpoint)

Using Buprenorphine in Opioid Treatment Programs: An Exploration of the Situation
Allan Cohen, MA, Bay Area Addiction, Research and Treatment, Sherman Oaks, CA; Leslie Amass, PHD, Friends Research Institute, Los Angeles, CA; Robert Lubran, MS, CSAT, Rockville, MD

Buprenorphine is the newest medication approved by the FDA for the treatment of opioid dependence. Currently, there are increasing interest and efforts to expand the use of buprenorphine into the OTP. This workshop will explore buprenorphine as well as the significant challenges that OTP provides must address to offer buprenorphine as a treatment option in their programs.

Click here to download handout (PDF)

Using Simple Microsoft Office Tools to Track, Measure and Report Patient Outcomes
Lawrence O'Toole, MA, Habit Management, Inc., Boston, MA; Carol Wertheimer, PsyD, Melrose-Wakefield Hospital, Lynn, MA

Learn how to integrate Microsoft Excel and Word to track and document patient outcomes, improve treatment, create reports and meet licensing and accreditation requirements. All participants will receive software that automatically creates tables, graphs and charts from simple data entered by program staff. Presenters will demonstrate how the software works and how participants can use the software tools within their clinics.

Click here to download presentation (Powerpoint)

To view and print the PDF files listed above, you will require the Adobe Reader. Click the icon below to download and install the software for your operating system.